Neo Ivy Capital Management’s NeoGenomics NEO Stock Holding History

Neo Ivy Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,491	Closed	-$24K	–	381
2024 Q4	$24K	Buy	+1,491	New	+$23.2K	﹤0.01%	247
2022 Q2	–	Sell	-3,528	Closed	-$42K	–	544
2022 Q1	$42K	Buy	3,528 +3,427	+3,393%	+$72.1K	0.04%	388
2021 Q4	$3K	Sell	101 -992	-91%	-$38.8K	﹤0.01%	406
2021 Q3	$34K	Buy	+1,093	New	+$50.6K	0.04%	361
2021 Q1	–	Sell	-3,246	Closed	-$175K	–	583
2020 Q4	$175K	Buy	+3,246	New	+$147K	0.2%	177
2020 Q3	–	Sell	-1,093	Closed	-$34K	–	563
2020 Q2	$34K	Buy	+1,093	New	+$30.3K	0.04%	361

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Neo Ivy Capital Management's NEO Position: Q1 2025 in Review

Neo Ivy Capital Management sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 1,491 shares — an estimated $24K sold.

Neo Ivy Capital Management first reported a position in NEO in Q2 2020 and held it in 6 quarters. The position peaked at $175K in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

Neo Ivy Capital Management reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 1,491 NeoGenomics shares in Q1 2025, an estimated $24K.
Neo Ivy Capital Management first reported a position in NeoGenomics in Q2 2020 and held it in 6 quarters.
Neo Ivy Capital Management's NeoGenomics position peaked at $175K in Q4 2020.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Neo Ivy Capital Management's 13F filing for Q1 2025, filed 6 May 2025.